We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nanoident Subsidiary Announces Technology Platform

By HospiMedica staff writers
Posted on 13 Sep 2006
Biodent Technologies Inc., (Menlo Park, CA, USA), a newly formed subsidiary of Nanoident Technologies AG (Linz, Austria), is developing an innovative technology platform whereby a new printing process is applied to organic semiconductor-based photonic sensors, which may have applications in molecular diagnostics and chemical analysis.

Basically, Biodent is developing an integrated biochip reader, combining microfluidic chips with opto-electronic detection circuitry for on-the-spot readout of diagnostic tests. More...
The integrated biochip reader offers several significant benefits over current diagnostic technology that will enlarge the variety of tests available to the medical, defense, and consumer markets.

An integrated reader will eliminate the need for bulky and extremely expensive external readers, enabling mobile diagnostics, immediate test results, and significant cost savings. The integrated biochip readers will be used for food and water analysis, chemical and biologic detection, and molecular diagnostics.

Nanoident is a nanotechnology company that develops organic semiconductor-based photonic sensors. The company produces opto-electronic sensors for market segments such as security and the life sciences.



Related Links:
Nanoident Technologies

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Preoperative Skin Preparation
BD ChloraPrep
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.